Cargando…
Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels
BACKGROUND: Development and progression of myxomatous mitral valve disease (MMVD) in dogs are difficult to predict. Identification at a young age of dogs at high risk of adverse outcome in the future is desirable. HYPOTHESIS/OBJECTIVES: To study the predictive value of selected clinical and echocard...
Autores principales: | Reimann, M.J., Møller, J.E., Häggström, J., Martinussen, T., Zatrazemi, S.S.C., Svanholm, L., Nielsen, L.B.M., Pedersen, H.D., Olsen, L.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508320/ https://www.ncbi.nlm.nih.gov/pubmed/28573754 http://dx.doi.org/10.1111/jvim.14759 |
Ejemplares similares
-
Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8‐ to 10‐Year Period
por: Birkegård, A.C., et al.
Publicado: (2016) -
Myoclonus in older Cavalier King Charles Spaniels
por: Rotter, Carina, et al.
Publicado: (2022) -
Morphometric analysis of spinal cord termination in Cavalier King Charles Spaniels
por: Sparks, Courtney R., et al.
Publicado: (2019) -
Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease
por: Reimann, Maria J., et al.
Publicado: (2021) -
No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response
por: Reimann, Maria J., et al.
Publicado: (2023)